1. Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years
- Author
-
Takayuki Namba, Takeshi Adachi, Akio Kawamura, Atsushi Sato, Yodo Gatate, Risako Yasuda, Nobuyuki Masaki, and Hirotaka Yada
- Subjects
medicine.medical_specialty ,Exacerbation ,medicine.medical_treatment ,Case Report ,030204 cardiovascular system & hematology ,tranexamic acid ,03 medical and health sciences ,0302 clinical medicine ,Oral administration ,Internal Medicine ,medicine ,Humans ,Aged ,Aortic dissection ,business.industry ,General Medicine ,Heparin ,Disseminated Intravascular Coagulation ,medicine.disease ,Antifibrinolytic Agents ,Surgery ,Aortic Aneurysm ,Aortic Dissection ,Coagulative necrosis ,Treatment Outcome ,Anesthesia ,Chronic Disease ,Female ,Hemodialysis ,Chronic disseminated intravascular coagulation ,business ,Tranexamic acid ,030215 immunology ,medicine.drug - Abstract
The management of chronic disseminated intravascular coagulation (DIC) caused by aortic dissection has not yet been established. Even in cases where surgical correction is performed, therapeutic control of systemic hemorrhaging is still required. We herein report the successful treatment of a case of aortic dissection with a patent false lumen using tranexamic acid for acute exacerbation of chronic DIC. Oral administration of 1,500 mg tranexamic acid per day stabilized the coagulative and fibrinolytic parameters and relieved bleeding tendencies with no side effects. Heparin was administered periodically for the management of hemodialysis. This favorable result continued for up to 3 years.
- Published
- 2017